期刊文献+

氯沙坦对X综合症大鼠糖脂代谢的影响 被引量:1

Effect of Losartan on Sugar and Lipid Metabolism in Syndrome x Rats
下载PDF
导出
摘要 目的探讨氯沙坦对x综合症大鼠糖脂代谢的影响.方法采用高果糖饲料饲养两肾一夹SD大鼠4周,诱导建立x综合症模型,实验随机分为对照组;x综合症组;对照组+氯沙坦组;x综合症组+氯沙坦组.每周检测各组尾动脉收缩压,于12周末采血测定各组血糖、血脂、血胰岛素水平,同时计算胰岛素敏感指数.结果x综合症组+氯沙坦组与x综合症组对比,氯沙坦降低了收缩压(P<0.01)、空腹血糖(8.01 mmol/l vs13.81 mmol/lP<0.01)、、甘油三酯(0.88 mmol/l vs 1.53 mmol/lP<0.01)、总胆固醇(0.79 mmol/l vs 1.57mmol/lP<0.01),升高了胰岛素敏感指数(-5.71 vs-6.40P<0.05).结论氯沙坦能降低x综合症大鼠的血压,减轻胰岛素抵抗,纠正糖、脂代谢紊乱.表1,图1,参12. Aim To investigate the effect of losartan on sugar and lipid metabolism in syndrome x rats. Methods: syndrome X was produced by two- kindey, one -cliped(2K1C)rats fed with high fructose diet for 4 weeks. The rats were randomly divided into four groups: Control, Syndrome X, Control + Losartan and Syndrome X + Losartan. Systolic blood pressure(SBP) was measured each week, fasting blood sugar( FBS), blood lipid, and the level of fast serum insulin(FSI) were measured respectively in groups at the time of 12 weekend,insulin sensitive index(ISI)was also calculated. Results:comparing Syndrome X + losartan group with Syndrome X group,losartan decreased systolic blood pressure ( P 〈 0.01 ) , fasting blood Sugar ( 8.01 mmol/l vs 13.81 mmol/l P 〈 0.01 ), triglyceride (0.88 mmol/l vs 1.53 mmol/l P 〈 0.01 ), blood total cholesterol(0.79 mmol/ l vs 1.57 mmol/l P 〈0.01 ) ,raised insulin sensitive index( -5.71 vs -6.40 P 〈0.05). Conclusion:losartan can reduce BP, to improve insulin resistance and correct the abnormity of sugar and lipid metabolism in syndrome x rats. 1tabs. ,12refs.
作者 周凯
机构地区 [
出处 《湖南环境生物职业技术学院学报》 CAS 2007年第2期15-18,共4页 JOurnal of Hunan Environment Biological Polytechnic
关键词 氯沙坦 X综合症 血糖 血脂 losartan syndrome x blood sugar blood lipid
  • 相关文献

参考文献1

二级参考文献7

  • 1Zavaroni I,Sander S,Scott S,et al.Effect of fructose feeding on insulin secretion and insulin action in the rat[J].Metabolism,1980,29:970.
  • 2Reaven GM, Ho H. Sugar-induced hypertension in Sprague-Dawley rats[J]. Am J Hypertens,1991,4: 610-614.
  • 3Taylor SI,Accili D, Imai Y. Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM?[J]. Diabetes,1994,43:735.
  • 4Miatello R,Risler N,Gonzalez S,et al. Effects of enalapril on the vascular wall in an experimental model of syndrome X[J]. Am J Hypertens,2002,1510(1):872.
  • 5Storlien LH, Oakes ND,Pan DA,et al.Syndromes of insulin resistance in the rat. Inducement by diet and amelioration with benfluorex[J]. Diabetes, 1993,42: 457.
  • 6李光伟.当前胰岛素敏感性评估及胰岛素抵抗研究中的某些误区[J].中华内科杂志,1998,37(2):81-83. 被引量:90
  • 7梁兴伦,韩明向,周宜轩,苏淑茵.四安胶囊对X综合征治疗效应的实验研究[J].中国实验方剂学杂志,1999,5(1):39-40. 被引量:12

共引文献6

同被引文献10

  • 1万炳军.运动影响代谢综合症的机制探讨[J].山西师大体育学院学报,2007,22(1):139-141. 被引量:4
  • 2肖婉琴,张静,陈亚奇,凌宏艳,龙光,胡弼.氯沙坦和替米沙坦对X综合征大鼠血糖、血脂的影响[J].南华大学学报(医学版),2007,35(3):321-325. 被引量:6
  • 3UngerT. The role of the renin - angiotens in system in the development of cardiovascular disease[J]. Am J Cardiol, 2002, (89) : 3-9.
  • 4Scheen A J. Prevention of type 2 diabetes mellitus through inhibition of the Renin - Angiotensin system[J]. Drugs, 2004, (64) : 2 537 - 2 565.
  • 5Henriksen E J, Jacob S, Kinnick T R, et al. Selective angiotensin Ⅱ receptor receptor antagonism reduces in - sulin resistance in obese Zucker rats[J]. Hyperten - sion, 2001, (38) : 884 - 890.
  • 6Michael S, Junkus C, Romain G, et al. Molecular Characterization of New Selective Peroxisome Prolifer- ator- Activated Receptor Modulators With Angioten - sin Receptor Blocking Activity [ J ]. Diabetes, 2005,(54) : 3 442-3 452.
  • 7Schupp M, Lee L D, Frost N, et al. Regulation of peroxisome proliferator- activated receptor gamma activity by losartan metabolites [J]. Hypertension,2006, (47) : 586- 589.
  • 8Janke J, Schupp M, Engelis, et al. Angiotens in typel receptor antagonists induce human in- vitro adipo- genesis through peroxisome proliferator- activated re- ceptor- gamma activation [ J ]. J Hypertens, 2006, (24) : 1 809 - 1 816.
  • 9ROBERTS C K, VAZIRI N D, BARNARD R J. Effect of dietand exercise intervention on blood pressure, insulin, oxidativestress and nitric oxide availability [ J ]. Circulation, 2002, 12 ( 106 ) : 2530 - 2532.
  • 10CHIRIAC S, JERCA L, UNGUREANU D, et al. The evaluation of oxidative stress and enzymatic antioxidants in medium term physical training of moderate hypertension [J]. Rev Med Chit Soc Med Nat Iasi, 2004, 108(1) :74 - 78.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部